ArticleNeuroepidemiology2026
Incidence and Survival of Central Nervous System Tumors in Reunion Island: A Population-Based Study.
Article in Neuroepidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary central nervous system (CNS) tumors are rare but carry significant morbidity and mortality worldwide. Epidemiological data in diverse populations, such as Reunion Island - a multiethnic French and European outermost region - remain scarce. While robust data are available for mainland France, to our knowledge, no comprehensive description of primary CNS tumors in the population of Reunion Island has yet been reported.
methodsWe analyzed primary CNS tumors diagnosed between 2006 and 2020 using the Reunion Island population-based cancer registry. We estimated age-standardized incidence rates, tumor subtype distributions, and survival outcomes and compared them with international data and those from mainland France.
resultsA total of 1,162 cases of primary CNS tumors were identified between 2006 and 2020. ASRs were 8.9 and 10.7 per 100,000 person-years in men and women, respectively. Meningiomas were the most frequent tumors (52.6%), with a markedly higher incidence in women. Glioblastomas represented 26.1% of cases and were more common in men (sex ratio M/F = 1.5), with an ASR of 3.3/100,000 person-years versus 1.8/100,000 person-years in women, and the median net survival was 11.5 months. Age-standardized net survival was 49.6% (95% confidence interval [95% CI]: 43.6-55.6) at 1 year and 6.5% (95% CI: 2.0-9.9) at 5 years.
conclusionThis first comprehensive population-based study of CNS tumors in Reunion Island reveals incidence and survival patterns comparable to those in mainland France, underscoring the value of cancer registries in diverse settings for informing healthcare planning and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.